UK markets open in 6 hours 50 minutes
NIKKEI 225
39,103.22 +486.12 (+1.26%) HANG SENG
18,868.71 -326.89 (-1.70%) CRUDE OIL
76.85 -0.02 (-0.03%) GOLD FUTURES
2,332.80 -4.40 (-0.19%) DOW
39,065.26 -605.78 (-1.53%) Bitcoin GBP
53,408.57 -1,144.07 (-2.10%)
CVS Health Corporation (CVS.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 08:08AM CEST
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 66.43B |
| Enterprise value | 129.73B |
| Trailing P/E | 10.08 |
| Forward P/E | 8.02 |
| PEG ratio (5-yr expected) | 1.46 |
| Price/sales (ttm) | 0.20 |
| Price/book (mrq) | 0.97 |
| Enterprise value/revenue | 0.39 |
| Enterprise value/EBITDA | 8.20 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.55 |
| 52-week change 3 | -16.83% |
| S&P500 52-week change 3 | 27.84% |
| 52-week high 3 | 74.62 |
| 52-week low 3 | 50.41 |
| 50-day moving average 3 | 63.25 |
| 200-day moving average 3 | 66.02 |
Share statistics
| Avg vol (3-month) 3 | 386 |
| Avg vol (10-day) 3 | 582 |
| Shares outstanding 5 | 1.26B |
| Implied shares outstanding 6 | 1.26B |
| Float 8 | 1.25B |
| % held by insiders 1 | 0.12% |
| % held by institutions 1 | 82.17% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 2.49 |
| Forward annual dividend yield 4 | 4.71% |
| Trailing annual dividend rate 3 | 2.48 |
| Trailing annual dividend yield 3 | 4.69% |
| 5-year average dividend yield 4 | 2.86 |
| Payout ratio 4 | 43.51% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 19 Apr 2024 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in USD.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 2.04% |
| Operating margin (ttm) | 2.13% |
Management effectiveness
| Return on assets (ttm) | 3.18% |
| Return on equity (ttm) | 10.09% |
Income statement
| Revenue (ttm) | 359.66B |
| Revenue per share (ttm) | 281.15 |
| Quarterly revenue growth (yoy) | 3.60% |
| Gross profit (ttm) | N/A |
| EBITDA | 16.92B |
| Net income avi to common (ttm) | 7.32B |
| Diluted EPS (ttm) | 5.25 |
| Quarterly earnings growth (yoy) | -47.90% |
Balance sheet
| Total cash (mrq) | 13.09B |
| Total cash per share (mrq) | 10.43 |
| Total debt (mrq) | 81.79B |
| Total debt/equity (mrq) | 110.31% |
| Current ratio (mrq) | 0.81 |
| Book value per share (mrq) | 59.08 |
Cash flow statement
| Operating cash flow (ttm) | 10.89B |
| Levered free cash flow (ttm) | 8.36B |
© 2024 Yahoo. All rights reserved.